GtoPdb Ligand ID: 7540

Synonyms: AMG-827 | AMG827 | Kyntheum® | Lumicef® | Siliq®
brodalumab is an approved drug (Japan (2016), FDA (2017), EMA (2017))
Compound class: Antibody
Comment: Brodalumab is a human monoclonal antibody designed for the treatment of inflammatory diseases. It targets the interleukin 17 receptor A (IL17RA).
Annotated peptide sequences for this antibody are available from its IMGT/mAb-DB record.
Compound class Antibody
Approved drug? Yes (Japan (2016), FDA (2017), EMA (2017))
International Nonproprietary Names
INN number INN
9475 brodalumab
AMG-827 | AMG827 | Kyntheum® | Lumicef® | Siliq®
Database Links
Specialist databases
IMGT/mAb-DB 376
Other databases
GtoPdb PubChem SID 187051841
PubChem SID 187051841
Search PubMed clinical trials brodalumab
Search PubMed titles brodalumab
Search PubMed titles/abstracts brodalumab
Wikipedia Brodalumab